MedPark Regeneration First

Professionals

ABOUT US

  • Vision

  • History

  • Global Network

Regenerative medical solution provider

MedPark
VISION 2025

IPO

KOREA
No.1

Asia-Pacific
No.1

Global
TOP10

First in Korea and Asia Completed clinical and commercialization,
acquired global certification MedPark's dream is the future of regenerative medical.

History

20
24
  • Collagen membrane Colla approved in Mexico
  • S1 approval obtained in Peru
  • Development of human soft tissues (Tendon, Costal Cartilage, Ligament)
23
  • Commercialization of human collagen products
  • S1 FDA certification obtained
21
  • Obtained the European CE marks for S1
  • Selected for 2021 K-Unicorn
20
  • Obtained World’s first European CE marks simultaneously for
    • - Xenograft(Bovine, Porcine)
    • - Collagen membrane
  • S1 global IP patent application and registration
  • MFDS permission for bone graft for medical use
19
  • Selected as a hidden champion
  • Supplied to the world's No. 1 implant manufacturer
  • Completed the 3rd factory and Seoul Research Institute
  • Won the 2019 Korea Small and Medium Business Regulatory Innovation Award
17~2018
  • Transitioned to incorporation(MedPark Co., Ltd.)
  • Awarded by the Minister of SMEs and Startups
  • Completed of 2nd factory (received 500 million KRW in free cash support from Busan)
  • Selected for government tasks for convergence of material parts technology
10~2015
  • Established MedPark
  • Achieved $1 million In exports
  • Completed company builiding

MedPark Biomedical

Global Network + Innovative technical skills =Leap Forward for the Global Brand

Securing over 200 global dealer channel networks

  • · Europe: World's first CE certification 3 products acquired and commercialized
  • · Main bases by continent, including China, and global dealer channels
  • · Greater China/North America: CFDA/FDA approval in progress
  • · Asia-Pacific/Middle East: National approvals and commercialization completed
  • · Latin America: Permits in progress for each country
  • Partnering with and supplying to major global major implant manufacturers